Edgewise Therapeutics, Inc. (EWTX) › Shareholders' EquityEdgewise Therapeutics, Inc. (EWTX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$16.85M2020: -$33.42M2021: $274.38M2022: $346.72M2023: $318.83M2024: $459.22M2025: $522.26M$522.26M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$522.26M+13.7%2024$459.22M+44.0%2023$318.83M-8.0%2022$346.72M+26.4%2021$274.38M+921.0%2020-$33.42M-98.3%2019-$16.85M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share